07:00 , Aug 2, 2010 |  BC Week In Review  |  Financial News

Omeros financial update

Omeros secured a two-year committed equity financing facility (CEFF) for up to $40 million from Azimuth Opportunity Ltd. Omeros Corp. (NASDAQ:OMER), Seattle, Wash.   Business: Inflammation, Neurology   Date announced: 7/29/10  ...
07:00 , Jul 5, 2010 |  BC Week In Review  |  Financial News

Durect financial update

Durect secured a two-year committed equity financing facility (CEFF) for up to $50 million from Azimuth Opportunity Ltd. Durect Corp. (NASDAQ:DRRX), Cupertino, Calif.   Business: Drug delivery   Date announced: 7/1/10  ...
07:00 , May 31, 2010 |  BC Week In Review  |  Financial News

Alexza financial update

Alexza secured a two-year committed equity financing facility for up to $25 million from Azimuth Opportunity Ltd. Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Mountain View, Calif.   Business: Drug delivery, Neurology   Date announced: 5/26/10  ...
08:00 , Jan 18, 2010 |  BC Week In Review  |  Financial News

Vical financial update

Vical secured a two-year equity facility for up to $25 million from Azimuth Opportunity Ltd. Vical Inc. (NASDAQ:VICL), San Diego, Calif.   Business: Cancer, Infectious, Gene/Cell therapy   Date announced: 1/8/10  ...
08:00 , Jan 4, 2010 |  BC Week In Review  |  Financial News

Poniard completes equity-based line of credit

Poniard Pharmaceuticals Inc. (NASDAQ:PARD), South San Francisco, Calif.   Business: Cancer   Date completed: 12/22/09   Type: Equity-based line of credit   Raised: $6.5 million   Shares: 3.5 million   Price: $1.87   Shares after...
08:00 , Dec 14, 2009 |  BC Week In Review  |  Financial News

Xoma financial update

Xoma received a letter of reprimand from NASDAQ for non-compliance with a rule for continued listing. The rule requires shareholder approval for the issuance of common shares or securities exercisable for common shares equal to...
08:00 , Nov 23, 2009 |  BC Week In Review  |  Financial News

Xoma financial update

Xoma received a letter from NASDAQ indicating that the company's September offering is not in compliance with a rule for continued listing. The rule requires shareholder approval for the issuance of common shares or securities...
08:00 , Nov 16, 2009 |  BC Week In Review  |  Financial News

Map Pharmaceuticals financial update

Map Pharmaceuticals secured a two-year committed equity financing facility for up to $60 million from Azimuth Opportunity Ltd. Map Pharmaceuticals Inc. (NASDAQ:MAPP), Mountain View, Calif.   Business: Inflammation, Neurology, Pulmonary   Date announced: 11/12/09  ...
07:00 , Oct 5, 2009 |  BC Week In Review  |  Financial News

Affymax financial update

Affymax secured a two-year equity facility for up to $60 million from Azimuth Opportunity Ltd. Affymax Inc. (NASDAQ:AFFY), Palo Alto, Calif.   Business: Cancer, Hematology   Date announced: 9/25/09  ...
07:00 , Sep 21, 2009 |  BC Week In Review  |  Company News

Xoma Ltd., Roche deal

Xoma sold its royalty rights to Lucentis ranibizumab to Roche's Genentech Inc. unit for $25 million. Xoma will use the money to help repay a $44.2 million loan to Goldman Sachs. Xoma expects to repay...